Private sector funded drug spending Canada by top drug classes share 2013

This statistic displays the proportion of the total drug program expenditures in Canada funded by the private sector, by the top 10 drug classes in 2013. In that year, 6.3 percent of total drug program spending funded by the private sector was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.

本统计数据展示了2013年加拿大药品计划总支出中，由私营部门资助的比例，以及前十大药品类别。当年，私营部门资助的药品计划总支出中，有6.3%用于资助HMG-CoA还原酶抑制剂（他汀类药物），此类药物常用于治疗高胆固醇症。